Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
MOL#104158
Channels and volume changes in the life and death of the cell
Herminia Pasantes-Morales
División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de
México, Mexico City, Mexico
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Running title: channels and cell volume
Prof. Herminia Pasantes-Morales
Instituto de Fisiología Celular
Av. Universidad 3000, Ciudad Universitaria, Mexico City, Mexico
Tel. 0155 5622 5608
0155 5622 5588
Fax. 0155 5622 5607
e-mail: [email protected]
Text pages:
Table number: 0
Figure number: 5
Abstract words: 196
Text words: 7513
Reference number: 146
Abbreviations: AMPA, α-Amino-3-hydroxy-5-methylisoxazole-4-propionic acid hydrate; DCPIB, 4-
[(2-Butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]butanoic acid; DIDS,
4,4B-diisothiocyanostilbene-2,2B-disulfonic acid; NKCC, Na+/K+/2Cl co-transporter; NMDA, N-
Methyl-D-aspartic acid; NPPB, 5-nitro-2-(3-phenylpropylamino) benzoic acid; OREBP, osmotic
Response Element-binding Protein; KCC, K+/Cl− co-transporter; Kv, voltage-gated K+ channels; KCa,
Ca2+
-activated K+ channels; KIR, inwardly rectifying K
+ channels; K2P, two-pore domain K
+ channels;
SITS, 4-acetamido-4'-isothiocyanatostilbene-2, 2'-disulfonic acid; SPAK, STE20/SPS1-related
proline/alanine-rich kinase kinases; SUR1, sulfonylurea receptor 1; TBOA, DL-threo-β-
benzyloxyaspartic-acid; TNF, tumor necrosis factor; TonEBP, tonicity-responsive enhancer binding
protein; TRPC, transient receptor potential channels; TRPM4, transient receptor potential
melastatin-4 channel; VSOAC, volume-sensitive organic osmolyte and anion channel; VRAC,
volume-regulated anion channel.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Address correspondence to: Herminia Pasantes-Morales, División de Neurociencias, Instituto de
Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico.
ABSTRACT
Volume changes deviating from original cell volume represent a major challenge for homeostasis.
Cell volume may be altered either by variations in the external osmolarity or by disturbances in the
transmembrane ion gradients that generate an osmotic imbalance. Cells respond to anisotonicity-
induced volume changes by active regulatory mechanisms that modify the
intracellular/extracellular concentrations of K+, Cl
-, Na⁺ and organic osmolytes, in the necessary
direction to reestablish the osmotic equilibrium. Corrective osmolyte fluxes permeate across
channels that have a relevant role in cell volume regulation and participate as causal actors in
necrotic swelling and apoptotic volume decrease. This review provides an overview of the types
of channels involved in either corrective or pathological changes in cell volume. The review also
underlines the contribution of TRP channels, notably TRPV4, in volume regulation after swelling,
and describes the role of TRPs in volume changes linked to apoptosis and necrosis. Lastly we
discuss findings showing that multimers derived from LRRC8A (leucine-rich repeat containing 8A)
gene are structural components of the volume-regulated Cl- channel (VRAC)and underlines the
intriguing possibility that different heteromer combinations comprise channels with different
intrinsic properties as to permeate the heterogenous group of molecules acting as organic
osmolytes.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Introduction
Cell volume is characteristic of each cellular lineage and is maintained with few variations through
the cell life. Conditions inducing changes in cell volume represent a major challenge for the cell
homeostasis, and this may even culminate in the cell death. In order to keep the cell volume
constant, water fluxes should be in equilibrium between the intracellular and extracellular
compartments. This occurs under conditions of isotonicity, but any fluctuations in the osmolarity
of the extracellular milieu or in the distribution of osmotically active solutes drives water fluxes in
the necessary direction to reach a new equilibrium, which disturbs cell volume. Except for cells in
the kidney and intestine, which normally face large variations in external osmolarity, the
extracellular milieu maintains a well-controlled osmolarity. This is modified only under
pathological conditions leading to hyponatremia or in other pathologies that alter the distribution
of osmolytes in the extra-intracellular compartments (Song and Yu, 2014; Pedersen et al., 2016).
The intracellular osmolarity also endures continuous variations due to transient and local osmotic
microgradients generated during physiological processes, such as uptake and release of
metabolites, cytoskeletal remodeling, synthesis and degradation of macromolecules, and
exocytosis and secretion (Pedersen et al., 2001; Strbák, 2011; Platonova et al., 2015), but even
these localized changes in cell volume should be regulated to prevent changes in the
concentration of molecules free in the cytosol, protein misfolding, or alterations in cell and
organelle architecture. Cell volume modifies during migration, proliferation and cell adhesion, and
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
therefore, volume change has been proposed as a signaling event for these processes (Lang et al.,
2005; Stutzin and Hoffmann, 2006; Dubois and Rouzaire-Dubois, 2012).
When volume is perturbed due to changes in the extracellular osmolarity, cells respond by
activation of a plethora of signaling pathways and mechanisms intended to protect them from the
challenge of volume change; remodeling of the cytoskeleton, changes in adhesion molecules,
activation of stress and survival signals are among the adaptive mechanisms triggered by the
altered volume (Pasantes-Morales et al., 2006; Pedersen and Hoffmann, 2009). At the same time,
cells set in motion an active regulatory process and tend to partially or fully restore the original
volume (Cala, 1977; Olson et al., 1986; Hoffmann, 1992; Okada, 2004). This adaptive mechanism,
which has been highly preserved during evolution, essentially consists of the redistribution of
osmotically active solutes in the necessary direction to equilibrate water fluxes facing the new
osmotic condition (Lang, 2007) (see Hoffmann et al., 2009 for a comprehensive review on cell
volume regulation). Osmolytes that accomplish cell volume regulation are the ions present in high
concentrations in the intracellular or extracellular compartments, such as Na+, K
+ and Cl
-, and a
group of heterogeneous organic molecules, such as amino acids, polyamines and polyalcohols
(Burg and Ferraris, 2008; Verbalis and Gullans, 1991; Pasantes-Morales et al., 1998). Volume-
regulated channels and cotransporters translocate ion osmolytes, and cotransporters and pores,
although not yet fully identified, mobilize organic osmolytes; channels participate predominantly
in the volume regulatory process activated by cell swelling, while cotransporters play a more
important role in the cell response to shrinkage (Khale et al., 2015). Besides their role in volume
regulation, channels are involved in the pathophysiological cell volume changes generated in
isotonicity that lead to necrotic death, as well as in those associated with apoptosis (Okada et al.,
2006; Bortner and Cidlowski, 1998; 2007). This review focus on i) channels permeating ions and
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
organic osmolytes during the regulatory volume decrease, ii) ion channels participating in the
volume regulatory increase, iii) channels implicated in normotonic cell volume changes leading to
apoptotic and necrotic cell death.
The Role of Channels in Regulatory Volume Decrease
A decrease in external osmolarity modifies the water concentration in the extracellular space,
which activates water inward-directed fluxes and increases the cell volume with a magnitude
proportional to the extent of the osmolarity change. As mentioned above, most animal cells
respond to this situation with an active process of volume recovery, known as regulatory volume
decrease (Cala, 1977), which is accomplished by extrusion of the major intracellular ions, K+ and
Cl-, and organic osmolytes. Most of the corrective fluxes occur via K
+ and Cl
- channels and diffusion
pathways for the organic osmolytes (Okada and Maeno, 2001; Hoffmann and Lambert, 1983;
Sánchez-Olea et al., 1991; Hoffmann et al., 2009)(Fig. 1).
K+
channels. K+ is a major intracellular osmolyte and contributes substantially to RVD. The
osmosensitive K+ fluxes permeate across a large variety of K
+ channels, and are involved in
multiple physiological processes in the cell other than volume regulation, but are triggered via
signals evoked by swelling. Four main classes of K+ channels are activated during RVD: voltage-
gated K+ (Kv) channels, Ca
2+-activated K
+ (KCa) channels, inwardly rectifying K
+ (KIR) channels, and
two-pore domain K+ (K2P) channels (Fig. 1). The kind of channel involved differs in the various cell
types and responds to one or several of the signals elicited by the volume change, such as
depolarization, membrane stretch, and elevation of intracellular Ca2+
[Ca2+
]i. In epithelial and
other cell types, swelling evokes a large increase in [Ca2+
]I, and RVD in these cells is consistently
Ca2+
-dependent due to the predominant role of KCa channels in the volume-corrective K+ fluxes.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
The high- and intermediate conductance K+ channels (BKCa, IKCa) are the channels mainly
implicated in RVD. BK channels are activated by swelling in the intestine, kidney and bronchial
epithelia, chondrocytes, pituitary tumor cells, and osteoblast-like cells (rev. in Hoffmann et al.,
2009). The activation of BK channels occurs by Ca2+
influx mediated by the TRPV4 subtype,
establishing a link between BKCa channels and some transient receptor potential (TRP) channels
(discussed below) (Jin et al., 2012). Intermediate-conductance (IKCa) channels participate in RVD in
T lymphocytes, erythrocytes, hepatocytes, osteosarcoma cells, intestine 407 cells, proximal tubule
cells, and lens epithelia (Rev. in Hoffmann et al., 2009). In other cells, such as brain cells, following
hypotonic swelling, depolarization generated by the Cl- efflux across the volume-regulated Cl
-
channel occurs, and in these cells, RVD is essentially Ca2+
independent (Pasantes-Morales et al.,
1994; Moran et al., 1997) and the K+ regulatory fluxes permeate across voltage-gated K
+ channels.
Subtypes of Kv involved in the different cell types include Kv1.3 in lymphocytes and murine
spermatozoa, Kv1.4.2 and Kv1.4.3 in myocytes, and Kv1.5 in lymphocytes and spermatoza. KCNQ1
(Kv7.1), in various subunit arrangements, participates in RVD in human mammary epithelial cells,
rat hepatocytes, cells from the inner ear and in mouse trachea epithelium (Rev. in Hoffmann et al.,
2009). The inwardly rectifying K+ channels Kir4.1 and Kir4.5, which sense small changes in
osmolarity (Grunnet et al., 2003; Soe et al., 2009), co-localize with AQP4 in the glial endfeet of the
blood-brain barrier, suggesting that they play a role in swelling and/or volume control in these
cells. Kir channels regulate extracellular K+ homeostasis during the K
+ spatial buffering through the
glial syncytium, and this transcellular K+ transport is accompanied by transmembrane water fluxes,
likely via a Kir4.1/AQP4 complex (Nagelhus et al. 1999; Dibaj et al., 2007). The two-pore domain K⁺
channels (K2P) participate in RVD in lymphocytes, Ehrlich ascites cells, astrocytes, and kidney cells
(Andronic et al., 2013; Niemeyer et al., 2001; Kirkegaard et al., 2010).
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
The variety of K⁺ channels involved in RVD in different cell types that are triggered by stimuli
concurrent with cell swelling raises the question about the existence of a purely swelling-gated K⁺
channel. A recent study, where AQP1 and a number of K⁺ channel types were co-expressed in
Xenopus oocytes (Tejada et al., 2014), identified the Kca 4.1 channel (Slick; Slo2.1) as the most
sensitive to volume changes. Slick currents increased markedly in hypotonicity and decreased in
hypertonicity, and these changes were not observed in the absence of AQP1, indicating that
channel activity follows the changes in cell volume and not in osmolarity. Thus, slick may be a
purely volume-sensitive K⁺ channel. Although Kca 4.1 was originally included in the Kca
nomenclature, it is now known that it is activated by internal Na⁺ and Cl- and not by Ca
2+.
The volume-regulated Cl-
channel. Volume-sensitive Cl-
fluxes play a key role in RVD; in
contrast to the diversity of K⁺ channels implicated in RVD in various cell types, Cl- fluxes permeate
across only one type of channel, the volume-regulated anion channel (VRAC), also named VSOR
(volume-sensitive outwardly rectifying anion channel). The channel is also referred to as VSOAC
(volume -sensitive organic osmolyte and anion channel) to denote that possibility that it
permeates organic osmolytes, but we will use VRAC throughout this review. VRAC, widely
expressed in animal cells, is essentially inactive under isotonic conditions and opens slowly by cell
swelling or by a decrease in ionic strength under isosmotic conditions (Emma et al., 1997; Voets et
al., 1999; Pedersen et al., 2016). In biophysical terms, the Cl- current (ICl
-swell) carried by VRAC
exhibits mild outwardly rectification and voltage inactivation at positive membrane potentials, and
this differs among cell types (Nilius et al., 1994; Nilius and Droogmans, 2001; Okada, 2004; Akita
and Okada, 2014). This outward rectification defines VRAC, and establishes clear differences from
other volume-sensitive Cl- channels, such as channels with no rectification (maxi-anion channel),
inward rectification (CLC2), steep outward rectification (Cl-C3 and anoctamine), or no rectification
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
(bestrophin). The single-channel VRAC conductance is 50–80 pS at positive and 10–20 pS at
negative membrane potentials, and VRAC exhibits a low field strength anion permeability
(I>Br>Cl>F). In this respect, VRAC differs from the ClC family members, which are typically selective
for chloride over iodide. VRAC permeates large molecules such as gluconate, glutamate, and
benzoate, and the pore size of this channel has been estimated to be about 11-17 A (Nilius et al.,
1997).
The search for VRAC specific blockers has been largely unsuccessful, but the long list of nonspecific
VRAC blockers (rev. in Pedersen et al., 2016) include: 1) conventional anion channel inhibitors,
such as DCPIB, DIDS, SITS, NPPB, and the acidic di-aryl-urea NS3728; 2) transporter blockers, such
as fluoxetin, phloretin and mefloquine; 3) the anti-estrogens tamoxifen, clomiphene, and
nafoxidine; 4) tyrosine kinase inibitors as genistein, tyrphostin A23, and PD98059; 5) purinergic
receptors blockers suramin, reactive blue 2 and PPADS; and 6) carbenoxolone and riluzol.
However, in addition to inhibiting VRAC, these inhibitors block a variety of other Cl-
channels,
transporters, or receptors to some extent (Pedersen et al. 2016). The failure to find a selective
VRAC blocker has complicated efforts to identify the molecular basis and proteins comprising for
this channel.
The VRAC gating mechanisms are not fully understood, but allosteric non-hydrolyzed-bound ATP
and permissive cytosolic Ca2+
are necessary for channel activation. It has been proposed that G-
protein-mediated signal transduction pathways and membrane structures, such as caveolin,
cholesterol, and actin cytoskeleton influence the channel activation mechanism, and it has been
suggested that the Ras-Raf-MEK-ERK pathway and the Rho/Rho kinase are modulators of VRAC
activity (Nilius et al., 1999). A volume-transduction pathway mediated by the epidermal growth
factor receptor and NAD(P)H oxidase-derived H2O2 has been proposed as a signaling pathway for
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
VRAC activation (Varela et al., 2004). Epidermal growth factor receptor is activated by
hyposmolarity and is an early signal that modulates osmolyte efflux pathways (Pasantes-Morales
et al., 2006). Additionally, reduction in ionic strength is a key element for VRAC activation; early
studies by the Nilius group (Nilius et al., 1998; Sabirov et al., 2000) demonstrated that reducing
ionic strength activates a Cl- current with biophysical and pharmacological features identical to
those of VRAC, even without cell swelling. This mechanism of VRAC activation is of high
physiological relevance. Under physiological conditions, the osmolality changes are small and
gradual, and in most cases, insufficient to generate significant changes in cell volume or in
membrane distension, but the osmotic disequilibrium still should be corrected. Corrective Cl-
fluxes permeating across VRAC, activated by local changes in the ionic environment, appear as the
best option for an isovolumetric regulation (see below). More direct evidence on the role of ionic
strength in VRAC gating is further discussed in the context of the identification of LRRC8 proteins
as components of the VRAC structure.
In 2014, two independent groups (Voss et al., 2014; Qiu et al., 2014), using a similar fluorescence
assay for a screening of human genome siRNA libraries, identified a multispan transmembrane
protein derived from a gene of unknown function named LRRC8A (leucine-rich repeat containing
8A). The LRRC8A subunit protein was postulated to be an integral component of the VRAC
structure. LRRC8A belongs to the LRRC8 family, which consists of five members, LRRC8A-LRRC8E.
All the LRRC8 proteins have four putative transmembrane domains and contain up to 17 leucine-
rich repeats. Studies by the above mentioned groups suggest that LRRC8 isoforms, similar to the
pannexins to which they are related, organize in heteromeric complexes to form a functional
channel with VRAC properties. It was also shown that the presence of LRRC8A in the multimeric
complex is essential, but not sufficient alone for VRAC activity, since at least one of the other
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
LRRC8 isoforms should be present together with LRRC8A. Genetic ablation of LRRC8B-LRRC8E did
not separately affect VRAC currents, but disruption of the five genes abolished VRAC activity. The
functional channel can be restored by expression of LRRC8A together with one of the other four
LRRC8 subunits (Voss et al., 2014; Qiu et al., 2014). The largest reductions in ICl(swell) amplitudes are
observed in LRRC8E−/−
and in LRRC8(C/E)−/−
cells and the lowest reductions in LRRC8B−/−
, LRRC8D−/−
cells (Voss et al., 2014). Different combinations of LRRCA and other heteromers define intrinsic
properties of the channel. Co-expression of LRRC8A and LRRC8E induces faster inactivation and
less positive potentials, while co-expression of LCRRC8A and LRRC8C has the opposite effect; this
co-expression markedly reduces the inactivation rate (Voss et al., 2014). Different combinations of
LCRR8 heteromers also strikingly modify VRAC permeability. As later discussed in detail, VRAC
permeability to taurine has a strict requirement of LCRR8A and LCRR8D, while LCRR8BCE subunits
appear unnecessary (Planells-Cases et al., 2015) (Fig. 2).
The possibility that LRRC8A constitutes the anion conducting pore domain of VRAC is questioned
(Akita and Okada, 2014) based on the lack of influence on currents across the LCRR8 complexes of
charged amino acids mutations in predicted transmembrane domains. This suggests that the
postulated VRAC structure may require a regulator molecule; a decrease, and not an increase, in
ICl(swell) following overexpression of LCRR8A also is suggestive of a regulator molecule. Recently,
Syeda et al. (2016) assembled models of different combinations of LCRR8A and LCRR8BD subunits
where the pore-forming channels were incorporated into bilayers. Using this approach, it was
possible to demonstrate that, as previously shown (Voss et al., 2014; Qiu et al., 2014), the
different combinations of LCRR8A with LCRR8B-D subunits determines intrinsic channel properties
such as rectification, inactivation kinetics, and relative anion permeability. The study also showed
that reducing intracellular ionic strength directly gates the channel, even in the absence of
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
mechanical changes in the membrane or the cellular components, such as cytoskeleton structures
or elements of signaling chains. The relevance of these findings is that differently composed
heteromers formed by combinations of LRRC8 subunits may result in a large variety of channels
with different intrinsic properties and different regulatory mechanisms, which helps explain the
differences in the inactivation rate of VRAC in various cell types and the possibility to permeate
molecules as heterogeneous as the group of organic osmolytes. It also points to the possibility that
one or many of the LCRR8 subunits forming VRAC contain the sensor for changes in ionic strength,
the proposed channel gating (Nilius et al., 1998; Sabirov et al., 2000; Cannon et al., 1998). The
relevance of the molecular identity of VRAC is extensively discussed in several excellent recent
reviews (Pedersen et al., 2015, 2016; Stauber, 2015; Jentsch et al., 2016).
Organic osmolytes. Organic osmolytes, which contribute to cell volume regulation in most
animal cells (Kinne, 1993), are small molecules of heterogeneous structure including amino acids
and derivatives (taurine, glutamate, glycine, GABA, and N-acetylaspartate), polyalcohols (myo-
inositol and sorbitol), and amines (glycerophosphorylcholine, betaine, creatine/P-creatine, and
phosphoethanolamine). The concentration of organic osmolytes varies in the different tissues;
glutamate, myo-inositol, creatine, taurine, and N-acetylaspartate are present in the highest
concentration in the brain (Verbalis and Gullans, 1991), whereas glycerophosphoryl choline,
betaine, myo-inositol and sorbitol are the major organic osmolytes in renal cells (Beck et al., 1992).
Organic osmolytes are important in the process of volume regulation; in contrast to ions, which
generate adverse effects that disturb the structure of macromolecules or affect neuronal
excitability, many organic osmolytes are compatible molecules. Thus, in the long term, organic
osmolytes tend to replace ionic osmolytes (Verbalis and Gullans, 1991). In the nervous system,
glutamate, GABA, and glycine are an exception since they play a dual role as osmolytes and
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
neurotransmitters, and therefore, changes in their concentration at the extracellular space disturb
nervous excitability or lead to neuronal death by excitotoxicity (discussed below). Taurine is
particularly suitable for an osmolyte role since it is largely free in the cytosol, is not a protein
amino acid, and participates in few reactions in the cell (Pasantes-Morales et al., 1998). Compared
to other osmolytes, taurine shows the largest efflux (9- to 22-fold) and the lowest osmolarity
threshold (Tuz et al., 2001), which could reflect a higher efficiency of the taurine efflux pathway or
more availability of taurine pools for release compared to osmolytes involved in other cell
functions.
The decrease in intracellular concentration of organic osmolytes as part of RVD is accomplished
largely by solute extrusion rather than by molecular degradation. Efflux of organic osmolytes
occurs via energy-independent, bidirectional leak pathways with net solute movements driven by
the concentration gradient (Hoffmann and Lambert, 1983; Sánchez-Olea et al., 1991). It has
consistently been reported that organic osmolyte fluxes are greatly reduced by VRAC blockers, but
it is still not known whether Cl- and organic osmolytes permeate across a common pathway, most
likely an anion channel like VRAC. The pore size of VRAC is sufficiently large as to permeate
osmolytes such as taurine and glutamate, and indeed currents carried by glutamate and anionic
taurine across VRAC have been demonstrated (Banderali and Roy, 1992). However, taurine is an
electroneutral zwitterion and at physiological pH, has no net charge, and is therefore unable to
permeate across an anion channel. The same is true for polyols and most organic osmolytes. A
number of differences between VRAC and the osmosensitive taurine efflux pathway have been
documented (Lambert and Hoffmann, 1994) and discussed in detail in reviews by Shennan (2008)
and Hoffmann et al. (2009). A most noticeable difference is the time course of Cl- (traced by
125I-)
and taurine efflux in various cell types (Stutzin et al., 1999; Pasantes-Morales et al., 1994; 1997)
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
(Fig.2); Studies showed that I- efflux is fast and rapidly inactivating, whereas taurine efflux is
slower and sustained (Fig. 2). As clearly underlined in Stutzin et al. (1999) and Shennan (2008), if
taurine and Cl- hypotonic fluxes were occurring via an identical pathway, such large differences in
the time course should not be observed. Though similar to VRAC-mediated currents, isotonic
taurine efflux is evoked by a decrease in ionic strength (Guizouarn and Motais, 1999: Cardin et al.,
1999). The recent discovery of the LRRC8 family of proteins forming volume-sensitive heteromeric
channels with different permeability offers a real possibility to establish the molecular identity of
the organic osmolyte efflux pathway(s). Studies by Voss et al. (2014), Qiu et al., (2014), and
Planells-Cases et al. (2015) show that in LRRC8A-/-
HEK, HCT116, and HeLa cells, the osmosensitive
taurine efflux is essentially abolished, stressing the importance of this LCRR8 family isoform for the
taurine efflux pathway, which issimilar to VRAC (Voss et al., 2014; Qiu et al., 2014) Interestingly,
also in 2014, a study by Hysinski-García et al. (2014) showed similar results in cultured astrocyte
from the mouse brain cortex. Astrocytes from primary cultures are not cell lines, but originate
from unmodified tissue, and therefore in this respect is noteworthy that LCRR8A is present in a
variety of mouse tissues (Qiu et al., 2014). The effects of genetic ablation of the different LCRR8
family isoforms on IClswell and on taurine efflux shown in studies by Voss et al. (2014) and Planells-
Cases et al. (2015) revealed that deletion of LCRR8A abolished both IClswell and taurine, deletion of
LCRR8E and C reduced IClswell (taurine efflux was not examined), and deletion of LCRR8D did not
affect IClswell, but markedly decreased the hypotonic taurine efflux (Planells-Cases et al., 2015).
Comparison of results in LRRC8(B,D,E)−/−
and LRRC8(B,C,D)−/−
cells confirmed that LRRC8D is
dispensable for IClswell, but indispensable for taurine fluxes. As predicted by Stutzin et al. (1999)
and Shennan (2008), these results indicate that the combination of LCRR8 heteromers, particularly
the presence or absence of the HCRRL8D subunit, confers two different molecular entities. In fact,
the HCRRL8D subunit, or lack of a subunit, confers two different channels, one for permeation of
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
anions and the other with high permeability to a neutral molecule, such as taurine. While both
channels have LCRR8A as an integral element and are activated by swelling/ion strength reduction,
these channels exhibit different intrinsic properties, such as inactivation and permeability,
suggesting that the pore structure must be significantly different in these two molecular entities; a
larger pore and differences in the amino acid residues between different combinations of LCRR8
subunits are necessary to permit the flow passage of molecules like taurine and other neutral
organic osmolytes. The predictable existence of a spectrum of channels constructed by multiple
combinations of LCRR8 subunits is relevant to understanding the puzzling existence of
permeability pathways for organic osmolytes that are not anions and have dissimilar molecular
structures, but are still gated by reduced ionic strength and inhibited by VRAC blockers.
The variety of LCRR8-based channels specific to permeate different osmolyte groups, including Cl-,
represent a useful tool to estimate the contribution of these different osmolyte pathways to cell
volume regulation. Presently, it has been shown that in LCRR8A-/-
HEK293, HeLa, and HCT116 cells,
RVD is attenuated, and in the cancer cell line BHY, RVD is abolished (Voss et al., 2014; Qiu et al.,
2014; Siriniant et al., 2016). These likely reflect differences in the contribution to the regulatory
process of other LCRR8A-independent mechanisms, such as the cotransporter KCC. Parallel
analysis of the effect of LCRR8A genetic ablation, together with blockers of KCCs as in HeLa cells in
the study by Siriniant et al. (2016), would help to clarify this question.
TRP channels. Transient Receptor Potential (TRP) channels are widely expressed in
vertebrate tissues and are cellular sensors for a large variety of stimuli. Most of the channels are
non-selective cation channels, with the exception of a few members that are Ca2+
selective. TRPs
of the mammalian superfamily are grouped into several subfamilies by sequence similarity (rev. in
Pedersen et al., 2005; Owsianik et al., 2006; Nilius and Owsianik, 2011; Nilius and Szallasi, 2014). A
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
member of the vanilloid subfamily, the TRPV4 channel, is an osmosensitive channel that
contributes to RVD in numerous cell types (Vriens et al., 2004; Plant, 2014), including
chondrocytes (Lewis et al., 2011.), corneal epithelial cells (Pan et al., 2008), keratinocyte cell lines
(Becker et al., 2005), salivary gland cells (Aure et al., 2010), and airway epithelial cells (Arniges et
al., 2004). In these cell types, RVD is Ca2+
-dependent and TRPV4 is proposed as the pathway for
Ca2+
influx evoked by swelling and the ensuing activation of KCa channels involved in RVD
(Fernández-Fernández et al., 2002, 2008; Jin et al., 2012). In astrocytes and retinal Muller cells,
TRPV4 is functionally linked to AQP4 (Benfenati et al., 2011; Jo et al., 2015), and this association is
a requirement for RVD. TRPV4 associates with AQP5 in acinar and salivary gland cells (Hosoi, 2016;
Liu et al., 2006) and with AQP2 in renal cells (Galizia et al., 2008).
The activation of TRPV4 by cell swelling is still unclear (Pedersen and Nilius, 2007), but the
following possibilities have been proposed: i) direct membrane stretch with integrins as
intermediate molecule (Matthews et al., 2010); ii) interaction with supramolecular complexes
containing regulatory kinases and cytoskeletal proteins (Becker et al., 2009); iii) interaction with
the arachidonic acid metabolite 5,6-EET (Watanave et al., 2003); and iv) phosphorylation by WNKs,
particularly WNK4 (Fu et al., 2006). Results of TRPV4 genetic manipulation suggest that its role is
not restricted to cellular processes of volume regulation, but that it is also implicated in systemic
osmosensing; TRPV4 genetic ablation alters functions, such as drinking behavior, serum
osmolarity, and antidiuretic hormone plasma levels (Liedtke and Friedman, 2003). Although the
mechanism is unclear, osmosensing neurons and cells in kidney epithelium express TRPV4 and
may represent its site of influence on systemic osmoregulation (Ciura and Bourke, 2006; Cohen,
2007).
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Other members of the TRPC family, such as TRPV1, TRPV2, TRPC1, TRPC5 and TRPC6, TRPM3,
TRPM7 are possibly involved in RVD; these channels are osmotically activated channels, but
detailed studies on their role in volume regulation are largely missing (Plant, 2014).
Isovolumetric Regulation
In most animal species, extracellular osmolarity is tightly regulated and abrupt, and large changes
in osmolarity rarely occur. In contrast, small and gradual changes in osmolarity associate with a
number of metabolic reactions and cell functions. Exposing cells to small and gradual osmolarity
reductions have shown that cells are able to maintain a constant volume over a wide range of
tonicities via an active mechanism of continuous volume adjustment. This adaptive response,
known as isovolumetric regulation (IVR), is accomplished by the efflux of intracellular osmolytes
(Lohr and Grantham 1986, Mountian and Van Driessche, 1997; Souza et al., 2000). The osmolytes
involved in IVR are the same as in RVD, i.e., Cl-, K
+ and organic molecules, and as shown in Figure 3,
the Cl- currents in glioma cells are evoked by gradual or sudden reductions in osmolarity. The Cl
-
current evoked by gradual osmotic reductions activates early, at osmolarity reductions of about
3%, and is blocked by niflumic acid and NPPB (Figure 3), which suggests that it’s similar to the
current across VRAC. This point should be clarified in light of new findings regarding the LCRR8
family members as integral elements of VRAC. K+ conductance also activates in these cells during
IVR with different osmolarity thresholds in the presence or absence of Ca2+
(Ordaz et al., 2004). In
a variety of cell types, gradual changes in osmolarity activate taurine efflux with different efflux
threshold (Souza et al., 2000; Pasantes-Morales et al., 2000, Ordaz et al., 2004), and the lowest
efflux is observed in cerebellar granule neurons where taurine efflux increases significantly at
osmolarity reductions of only 2 mOsm (Figure 3)(Tuz et al., 2001). This compensatory mechanism
is then likely to be preferred by neurons facing physiological changes in cell volume.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Channel-Transporter Interactions in RVI
Increase in external osmolarity activates intracellular water exit driven by osmotic disequilibrium,
and accordingly, this leads to a decrease in cell volume. If this is not corrected, cells undergo
apoptotic death. In healthy cells, hypertonicity activates a regulatory mechanism that aims to
restore normal cell volume even if the external anisotonic condition persists. This adaptive
mechanism, known as regulatory volume increase (Burg et al., 2007), occurs once a set of
mechanisms that increase the concentration of intracellular osmolytes are set in motion. This
tends to re-establish the osmotic equilibrium between extracellular and intracellular
compartments. Electroneutral cotransporters and ion exchangers both participate in this process
to increase the cytosolic levels of Na⁺ and Cl- (Figure 4), while NCC and NKCC family cotransporters
(Arroyo et al., 2013) and Na⁺/H exchangers are the main contributors to RVI (Cala et al., 1980;
Alexander and Grinstein 2006). Organic osmolytes are also significantly involved in RVI (Figure 4);
cell shrinkage increases the expression of Na⁺-dependent cotransporters known to operate for
various molecules acting as organic osmolytes (Sánchez-Olea et al., 1992; Burg and Ferraris, 2008).
In contrast to RVD where the corrective fluxes of osmolytes permeate essentially across ion
channels and to diffusive pathways for organic osmolytes, in RVI, channels play only a minor role
and the regulatory process is essentially accomplished by cotransporters and exchangers. It has
been proposed that unidentified hypertonicity-activated cation channels participate in RVI
(Wehner et al. 2006). A study in HeLa cells (Wehner et al. 2006) showing RVI reduction by SKF-
96365, a blocker of TRP channels, raised the question of whether the hypertonicity-induced cation
channels are actually TRP channels, and recent evidence pointed to the TRPM2 channel. A recent
report, also in HeLa cells (Numata et al., 2012), showed that nucleotides adenosine diphosphate
ribose (ADPr) and cyclic ADPr, reported as typical TRPM2 activators (Pedersen et al., 2005;
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Pedersen and Nilius, 2007), generate cation currents similar to those elicited by hypertonicity,
previously known as hypertonicity-activated cation channels. In the same line, siRNA silencing of
TRPM2 expression or the precursor enzyme of the TRPM2 nucleotide activators abolish the
hypertonicity-elicited cation current and mildly reduce RVI. Cloning of TRPM2 identified the ΔC-
splice variant as the molecular entity corresponding to the nucleotide-activated current (Numata
et al., 2012), which suggests that TRPM2 may represent the molecular identity of the
hypertonicity-activated cation channels. Another member of the TRP channel family, TRPV2,
seems to participate in RVI via an interesting connection with the electroneutral cotransporter
NKCC, which as previously mentioned, is a main effector in RVI. The suggested mechanistic chain
of events relating TRPV2 channels and RVI involves a TRPV2-dependent accelerated depolarization
followed by Ca2+
release from intracellular sources and the subsequent phosphorylation of
STE20/SPS1-related proline/alanine-rich kinase kinases (SPAK), which is essential for activation of
NKCC. This proposed pathway is supported by studies in skeletal muscle showing that expression
of TRPV2 negative dominant reduces the RVI efficiency at the time that depolarization is impaired
and the Ca2+
response is diminished (Zanou et al., 2015). Interestingly, the upregulation of all
transporters involved in RVI, ions and organic osmolyte transporters, occurs by the concerted
action of transcription factor TonEBP/OREBP. As part of the regulatory response to cell volume
decrease, TonEBP/OREBP increases the expression of osmoprotective genes, including Na⁺-
dependent transporters, responsible for the accumulation of organic osmolytes (Ferraris and Burg,
2006).
Channels Involved in Volume Changes in Necrotic and Apoptotic Death
Changes in cell volume are characteristic features of cell death and represent one of the main
differences between necrosis and apoptosis. In necrotic death, cell swelling and depletion of
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
intracellular ATP are distinctive traits. During the necrotic process, water accumulates into the
cytosol and organelles, and the membrane surface architecture is deformed by prominent,
stationary blebs that eventually lead to membrane rupture and cell death (Jurkowitz-Alexander et
al., 1992; Barros et al., 2001). In apoptosis, reduction in cell volume is a central event and a
hallmark in this program of cell death (Yu and Choi, 2000; Bortner and Cidlowsi, 1998). Coined
phrases for these cell volume changes include Apoptotic volume decrease (Hughes et al., 1997;
Maeno et al., 2000) and necrotic volume increase , also known as oncotic swelling or cytotoxic
swelling. A variety of channels are involved in these changes in cell volume.
Necrotic volume increase. Necrosis associates with the extensive cell loss that
accompanies pathological conditions, such as ischemia and ischemia/reperfusion, cardiovascular
diseases, and several neurodegenerative conditions. Cytotoxic swelling in ischemia results from
the arrest of oxygen-dependent ATP synthesis, which reduces the activity of the Na+/K
+ ATPase,
impedes the transmembrane Na+/K
+ exchanges, and results in dissipation of ion gradients. In brain,
swelling during ischemia is the first step in a cascade of ion gradient disturbances between the
intravascular and extracellular compartments that culminates in blood brain barrier injury and
vasogenic edema (Annunziato et al., 2013, Kahle et al., 2015). Besides ischemic swelling, brain cells
also swell during trauma, seizures, and spreading depression. Swelling is essentially due to Na⁺, K⁺
and Cl- overload, which drives inwardly-directed water fluxes, and both channels and
cotransporters participate in this process (Figure 5). Characteristic of brain ischemia is the marked
increase in extracellular K⁺ (K+
o), which is often elevated from a physiological level of around 3 mM
up to 60 mM. This high K+
o level reverses the KCC direction, and together with the ischemia-
activated expression of NKCC, results in large inwards ion and water fluxes (Khale et al., 2015). Na⁺
influx also permeates across a non-specific cation channel, which based on recent evidence, is
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
identified as TRPM4. The TRPM4 pore is selective for monovalent cations with similar permeability
for K⁺ and Na⁺, and is impermeable to divalent cations. Evidence in support of TRPM4 as a major
mechanism for Na+ influx in ischemia includes the following observations: i) two main regulators of
TRPM4, i.e., ATP and intracellular Ca2+
are deeply disturbed by conditions promoting necrosis. This
deregulation favors the opening of TRPM4, Na⁺ overload and NVI; ii) redox imbalance by excessive
generation of free radicals, a condition related to pathologies leading to necrosis, induces a
sustained activity of TRPM4 (Simon et al., 2010); iii) pharmacological or genetic manipulation of
TRPM4 has a marked influence on the swelling phase of the necrotic process; iv) activation of
TRPM4 channel by ATP depletion in COS-7 cells leads to depolarization and progressive bleb
formation (Chen and Simard, 2001; Chen et al., 2003), but this is not observed in cells lacking the
channel (Simard et al., 2012); and v) induced upregulation of TRPM4 protein in endothelial cells
from human umbilical vein causes Na⁺ overload, cell volume increase, and necrotic death, effects
which are prevented by pharmacological inhibition of the channel (Gerzanich et al., 2009; Becerra
et al., 2011). It should be noted that ADP and AMP are reported to block TRPM4b currents (Nilius
et al., 2004), however, during the first minutes of ischemia, ADP levels decrease in parallel to ATP
and AMP levels increase ( Guarnieri et al., 1993; Phillis et al.,1995). Regardless, the concentration
of AMP is so low (3% and 5% of ATP levels in heart and brain, respectively) (Muscari et al., 1993;
Phillis et al.,1995) that the increase may not affect TRPM4 activation. TRPM4 is not constitutively
present in the central nervous system, but is transcriptionally upregulated in neurons, astrocytes,
oligodendrocytes, and microvascular endothelial cells after the onset of ischemia (Gerzanich et al.,
2009). Necrotic death of endothelial cells caused by TRPM4 activation is also responsible for the
capillary fragmentation, known as progressive hemorrhagic necrosis, observed in traumatic injury
of the spinal cord. The capillary damage is prevented in TRPM4−/−
or by antisense
oligodeoxynucleotides directed against TRPM4 (Gerzanich et al., 2009). TRPM4 channel also
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
contributes to cytotoxic swelling, cell death, blood-brain barrier breakdown, and vasogenic edema
in ischemia and trauma (Simard et al., 2014; Zbeckberger et al., 2014; Martinez-Valverde et al.,
2015). Together, these findings are consistent with the idea that the TRPM4 channel plays a role in
cell swelling and necrotic death. Other channels, including members of the TRP family (TRPV4,
TRPM2, and TRPM7) and the acidic-activated cation channels, also increase in expression and
functional activity after an ischemic episode, and their blockade reduces the size of the infarct.
However, their role in inducing ischemic injury is more related to Ca2+
overload and protease
activation than to cytotoxic swelling.
In brain cells, VRAC participates in cytotoxic swelling and ulterior necrotic neuronal death,
particularly in the penumbra where intracellular ATP that is necessary for VRAC activation still
remains. Neuronal death results from the increase in extracellular glutamate driven by the reversal
of Na+-energy-dependent transporters and the swelling-activated, VRAC-mediated glutamate
efflux from swollen astrocytes (Mongin, 2016). The consequent overactivation of AMPA and
NMDA ionotropic receptorscauses Na+ and Ca
2+ overload at the same time that the ischemic
depolarizing condition activates VRAC in neurons, moving Cl-
into the cell driven by its
electrochemical potential. All this culminates in NVI and a necrotic cascade. The effect of VRAC
blockers on reducing both swelling and neuronal death (Inoue et al., 2007; Mongin, 2016) suggests
that VRAC has a in this deleterious effect. Necrosis is a delayed pattern of excitotoxicity, but
NMDA receptor overfunction also activates the apoptotic machinery (Linnik et al., 1993).
Hemichannels, the constituent elements of the Gap junctions, allow transmembrane movements
of large groups of heterogeneous molecules of different sizes, such as water, Na⁺, K+, Ca
2+, ATP, or
adenosine, among others. Hemichannels are expressed in the membrane of astrocytes, neurons,
oligodendrocytes, and vascular endothelium. Unregulated hemichannels have been implicated in
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
hypoxia, ischemia, and brain trauma where they generate disruption of intracellular ionic
homeostasis and cytotoxic swelling. Consistent with this action, downregulation of hemichannels
reduce cell swelling in astrocytes and reduce the ischemic injury (Davidson et al., 2015).
Apoptotic volume decrease. Apoptosis, or programmed cell death, is a physiological
mechanism that commits cells to individual death fate (Kerr, 1972). Apoptosis occurs normally
during development and aging to maintain optimal cell populations and eliminate excessive or
potentially harmful cells as an homeostatic mechanism. Apoptosis is characterized by changes in
the cell structure, notably cell nuclear condensation and DNA fragmentation, membrane blebbing,
and the formation of apoptotic bodies. Programmed cell death is activated by either intrinsic or
extrinsic stimuli. Intrinsic stimuli are molecules or situations of stress that result in mitochondrial
dysfunction, like UV radiation, nitric oxide, staurosporine, thapsigargin, and dexamethasone,
while extrinsic stimuli are ligands of death receptors such as Fas or other members of the tumor
necrosis factor receptor superfamily including CD95. As mentioned above, cell volume decrease is
a characteristic trait of apoptotic death, and depending on the cell type, the decrease in cell
volume may be in the range of 40-80%. The term apoptotic volume decrease was coined for this
unique condition (Hughes et al., 1997; Maeno et al., 2000). In terms of time-course, AVD occurs in
two phases, an initial phase which starts 0.5-2 h after exposure to the inductor and a late phase
detected about 3 h later. The two phases of AVD are accomplished by the same mechanism that
includes outwards fluxes of K⁺ and Cl- moving across specific channels and a decrease in osmolyte
intracellular concentration and water outflow resulting in AVD (Kondratskyi et al., 2014). It has yet
to be determined whether this decrease in cell volume is a passive factor or an active signal in the
induction of apoptosis, but evidence does exist that points to an explicit role of volume decrease
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
in the apoptotic process; blockade of the main osmolyte pathways that reduce AVD impairs the
progression of apoptosis (Grishin et al., 2005; Yu et al., 2000).
The increase in K⁺ currents that were detected as an early event in the cell death program (Yu et
al., 1997) first suggested that K⁺ channels contribute to AVD. Regardless of the cell type or the
inductor stimulus, the role of K⁺ channels as the K⁺ efflux pathway leading to AVD and loss of
intracellular potassium is recognized as a distinctive feature in the apoptotic program, (rev in Burg
et al., 2006; Bortner and Cidlowski, 2007; Orlov et al., 2013). A diversity of K⁺ channels mediate the
K⁺ efflux during AVD in different cell types; voltage-gated, Ca2+
-activated of intermediate and
large-conductance K⁺ channels, inward rectifier, and two-pore domain K⁺ channels participate in
AVD. Different subtypes of Kv channels contribute to AVD including Kv 1.2 and Kv 2.1 in neurons,
Kv 1.3 in T-lymphocytes, and Kv1.5 in COS-7 and in vascular smooth muscle. Kv channels of not
defined subtypes account for AVD and K⁺ loss in hippocampal neurons, sympathetic neurons,
cerebellar granule neurons, corneal epithelial cells, and cardiomyocytes (Rev. in Remillard and
Yuan, 2004; Bortner and Cidlowski, 2007; Lang et al., 2007). The intermediate-conductance IKCa
channels mediate the apoptotic K⁺ current in lymphocytes, thymocytes, and glioblastoma cells,
and the large-conductance BK channels play this role in artery smooth muscle cells, glioma, and
superficial colonocytes, while inward rectifier IRK channels are involved in apoptosis in liver cells,
HeLa cells, and some neuronal cell lines (Rev. in Bortner and Cidlowski, 2007). Members of two-
pore-domain potassium channels TASK1 and TASK3 participate in apoptosis in cerebellar granule
neurons and in exocrine pancreatic cells (Patel and Landunski, 2004). Hydrogen peroxide-
mediated apoptosis is associated with activation of TREK channels and of HERG K⁺ channels. The
significance of intracellular K⁺ decrease in the apoptotic process is more complicated than simply
an involvement as an osmolyte and a main contributor to AVD. The decrease in intracellular K⁺
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
levels has an effect on apoptotic mechanisms, independent of AVD, and is more related to the
release of cytochrome C (Yu, 2003; Remillard and Yuan, 2004). Various K⁺ channel subtypes
localized at the mitochondrial membrane regulate mitochondrial volume and contribute to the
organelle homeostasis.
Together with K+, Cl
- efflux is an essential component of AVD, during which K⁺ efflux hyperpolarizes
the cell and is followed by a Cl- outwards movement directed by its electrochemical gradient, thus
maintaining the ionic balance and electroneutrality of the cell. Activation of anion currents facing
intrinsic and extrinsic apoptotic stimuli is observed in a variety of cells (Okada et al., 2006), and
these anion currents are similar to those carried by VRAC regarding outward rectification, ATP
dependence, and pharmacological profile. However, VRAC is activated by a swelling and ionic
strength reduction, whereas volume decrease and ionic strength increase characterizes apoptosis.
Therefore, if VRAC participates in AVD, the channel volume set point must shift to a lower level or
the channel is gated by other mechanisms. Overproduction of reactive oxygen species, or a change
in cytosolic ATP, both concurrent with AVD, may be signals to either reduce the set point or to
modify an hypothetic modulator (Shimizu et al., 2008). While this critical point is not as yet
clarified, there is evidence showing that AVD induction is reduced by VRAC blockers in various cell
types. Although it should be considered that those blockers are not specific for VRAC or for Cl-
channels. The recent findings identifying LCCR8A as a structural element of VRAC provides
additional tools to define the VRAC contribution to AVD. The study by Planells-Cases et al. (2015)
in KBM7 and HAP1 cells showed that a channel formed by the combination of LCRR8A and LCRR8D
subunits participates in AVD and apoptosis. This channel composition is similar to that proposed to
permeate taurine flow, and dissimilar to the typical VRAC. In contrast, in HeLa cells, Sirianant et al.
(2016) reported no effect of LCRR8A knockdown in staurosporin-induced cell shrinkage.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
The significant role of organic osmolytes in cell volume regulation either in RVD and in RVI is well
documented, as above discussed. In contrast, evidence regarding organic osmolytes’ contribution
to volume decrease during apoptosis is rather scarce (Wehner et al., 2003). Although, the
importance of organic osmolytes was emphasized in the quantitative analysis made by Model
(2014), which demonstrated that the loss of organic molecules is necessary to account for the
osmotically obligated water exit in AVD. While taurine cell loss is documented in apoptosis in
Jurkat lymphocytes (Lang et al., 1998) and in cerebellar granule neurons (Moran et al., 2000), in
VRAC, taurine efflux is evoked by cell swelling or ionic strength reduction, two conditions absent in
apoptosis. A number of studies report antiapoptotic effects of taurine (Lambert et al., 2015), but
this seems unrelated to AVD. Recent findings that demonstrate resistance to cancer
chemotherapy by platinum-based drug show attenuated taurine efflux and reduced expression of
LCRR8D, suggesting a role for the LRRC8D containing VRAC entity in drug extrusion (Planells-Cases
et al., 2015; Voets et al., 2015). As for apoptosis, the normotonic activation of VRAC under these
conditions remains to be defined.
Comparing RVD and AVD mechanisms demonstrates that essentially the same type of K⁺ channels
participate in both processes in the same cell type. For instance, voltage-dependent Kv channels
are those involved in both RVD and AVD in neurons while Ca2+
-activated K⁺ channels are
implicated in epithelial cells. This selectivity is explained in the thermodynamic analysis of ion
fluxes described in Orlov et al (2013). The analysis in Orlov`s review refers only to AVD, but
appears valid also for K+ and Cl
- fluxes kinetics in RVD. Interestingly, activation of channels in AVD
occurs under isotonic conditions, suggesting marked differences in the intracellular signals
responsible for the efflux of osmolytes during the two processes. Also, the sustained cell shrinkage
during AVD does not result in activation of RVI (Maeno et al., 2006) in cisplatin‐induced cell
shrinkage and subsequent apoptotic cell death
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Concluding Remarks
The key role of ion channels in together with cotransporters in the active processes of cell volume
regulation is now well-established. The intricate and complex signaling pathways directed to
activate/inactivate these channels represents a vast field for present and future research. The firm
establishment of the molecular identity of the volume-regulated anion channel and the pore(s) for
permeation of organic osmolytes are also intriguing aspects in the physiology of volume-related
channels. Identification of the mechanisms responsible for cytotoxic swelling may ideally
contribute to the formulation of drugs with the potential to prevent the chain of events disturbing
the ionic homeostasis that ultimately result in brain edema. Although there is extensive literature
reporting drugs and maneuvers directed to reduce swelling and injury due to ischemic episodes,
all have failed in clinical trials. There is, however, also strong evidence of their relevance in the ion
gradient disturbances generating cytotoxic and vasogenic brain edema. The ischemic phenomenon
is complex and involves a plethora of factors and signals, complicated further by those resulting
from reperfusion. A comprehensive understanding of the events concurrent with
ischemia/superfusion, including those related to the channels involved, is part of the integral
approach necessary to formulate effective therapeutic targets for this pathology
Work in the author’s laboratory is supported by Dirección General de Asuntos del Personal
Académico (DGAPA) at the Universidad Nacional Autónoma de México (UNAM) [grant number
PAPIIT IN205916 ]. I deeply appreciate the invaluable help of Dr. Gerardo Ramos-Mandujano in
the preparation of the manuscript and figures
Author contribution: This is a single author review.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
References
Akita T and Okada Y (2014) Characteristics and roles of the volume-sensitive outwardly rectifying
(VSOR) anion channel in the central nervous system. Neuroscience 275: 211-231.
Alexander RT and Grinstein S (2006) Na+/H+ exchangers and the regulation of volume. Acta
Physiol 187: 159-167.
Andronic J, Bobak N, Bittner S, Ehling P, Kleinschnitz C, Herrmann AM, Zimmermann H, Sauer M,
Wiendl H, Budde T, Meuth SG, Sukhorukov VL (2013) Identification of two-pore domain potassium
channels as potent modulators of osmotic volume regulation in human T lymphocytes. Biochim
Biophys Acta 1828:699-707
Annunziato L, Boscia F, and Pignataro G (2013) Ionic transporter activity in astrocytes, microglia,
and oligodendrocytes during brain ischemia. J Cereb Blood Flow Metab 33: 969-982.
Arniges M, Vázquez E, Fernández-Fernández JM, and Valverde MA (2004) Swelling-activated Ca2+
entry via TRPV4 channel is defective in cystic fibrosis airway epithelia. J Biol Chem 279: 54062-
54068.
Arroyo JP, Kahle KT, and Gamba G (2013) The SLC12 family of electroneutral cation-coupled
chloride cotransporters. Mol Aspects Med 34: 288-298.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Aure MH, Røed A, and Galtung HK (2010) Intracellular Ca2+ responses and cell volume regulation
upon cholinergic and purinergic stimulation in an immortalized salivary cell line. Eur J Oral Sci 118:
237-244.
Banderali U and Roy G (1992) Anion channels for amino acids in MDCK cells. Am J Physiol 263:
C1200-C1207.
Barros LF, Stutzin A, Calixto A, Catalan M, Castro J, Hetz C, and Hermosilla T (2001) Nonselective
cation channels as effectors of free radical-induced rat liver cell necrosis. Hepatology 33: 114–122.
Becerra A, Echeverria C, Varela D, Sarmiento D, Armisen R, Nunez-Villena F, Montecinos M, and
Simon F (2011) Transient receptor potential melastatin 4 inhibition prevents lipopolysaccharide-
induced endothelial cell death. Cardiovasc Res 91: 677-684.
Beck FX, Sone M, Dörge A, and Thurau K (1992) Effect of increased distal sodium delivery on
organic osmolytes and cell electrolytes in the renal outer medulla. Pflugers Arch 422: 233-238.
Becker D, Blase C, Bereiter-Hahn J, and Jendrach M (2005) TRPV4 exhibits a functional role in cell-
volume regulation. J Cell Sci 118: 2435-2440.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Becker D, Bereiter-Hahn J, and Jendrach M (2009) Functional interaction of the cation channel
transient receptor potential vanilloid 4 (TRPV4) and actin in volume regulation. Eur J Cell Biol 88:
141-152.
Benfenati V, Caprini M, Dovizio M, Mylonakou MN, Ferroni S, Ottersen OP, and Amiry-Moghaddam
M (2011) An aquaporin-4/transient receptor potential vanilloid 4 (AQP4/TRPV4) complex is
essential for cell-volume control in astrocytes. Proc Natl Acad Sci U S A 108: 2563-2568.
Bortner CD and Cidlowski JA (1998) A necessary role for cell shrinkage in apoptosis. Biochem.
Pharmacol 56: 1549-1559.
Bortner CD and Cidlowski JA (2007) Cell shrinkage and monovalent cation fluxes: role in apoptosis.
Arch Biochem Biophys 462: 176-188.
Burg ED, Remillard CV, and Yuan JX (2006) K+ channels in apoptosis. J Membr Biol 209: 3-20.
Burg MB, Ferraris JD, and Dmitrieva NI (2007) Cellular response to hyperosmotic stresses. Physiol
Rev 87: 1441-1474.
Burg MB and Ferraris JD (2008) Intracellular organic osmolytes: function and regulation. J Biol
Chem 283: 7309-7313.
Cala PM. (1977) Volume regulation by flounder red blood cells in anisotonic media.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
J Gen Physiol. 69:537-552.
Cala PM (1980) Volume regulation by Amphiuma red blood cells. The membrane potential and its
implications regarding the nature of the ion-flux pathways. J Gen Physiol 76: 683-708.
Cannon CL, Basavappa S, and Strange K (1998) Intracellular ionic strength regulates the volume
sensitivity of a swelling-activated anion channel. Am J Physiol 275:C416-C422.
Cardin V, Peña- Segura C, and Pasantes-Morales H (1999) Activation and inactivation of taurine
efflux in hyposmotic and isosmotic swelling in cortical astrocytes: role of ionic strength and cell
volume decrease. J Neurosci Res 56:659-667.
Chen M and Simard JM (2001) Cell swelling and a nonselective cation channel regulated by
internal Ca2+ and ATP in native reactive astrocytes from adult rat brain. J Neurosci 21: 6512-6521.
Chen M, Dong Y, and Simard JM (2003) Functional coupling between sulfonylurea receptor type 1
and a nonselective cation channel in reactive astrocytes from adult rat brain. J Neurosci 23: 8568-
8577.
Ciura S and Bourque CW (2006) Transient receptor potential vanilloid 1 is required for intrinsic
osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses
to systemic hyperosmolality. J Neurosci 26: 9069-9075.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Cohen DM (2007) The transient receptor potential vanilloid-responsive 1 and 4 cation channels:
role in neuronal osmosensing and renal physiology. Curr Opin Nephrol Hypertens 16: 451-458.
Davidson JO, Green CR, Bennet L, and Gunn AJ (2015) Battle of the hemichannels--Connexins and
Pannexins in ischemic brain injury. Int J Dev Neurosci 45: 66-74.
Dibaj P, Kaiser M, Hirrlinger J, Kirchhoff F, and Neusch C (2007) Kir4.1 channels regulate swelling of
astroglial processes in experimental spinal cord edema. J Neurochem 103: 2620-2628.
Dubois JM and Rouzaire-Dubois B (2012) Roles of cell volume in molecular and cellular biology.
Prog Biophys Mol Biol 108:93-97
Emma F, McManus M, and Strange K (1997) Intracellular electrolytes regulate the volume set
point of the organic osmolyte/anion channel VSOAC. Am J Physiol 272: C1766-C1775.
Fernández-Fernández JM, Nobles M, Currid A, Vázquez E and Valverde MA (2002) Maxi K+ channel
mediates regulatory volume decrease response in a human bronchial epithelial cell line. Am J
Physiol Cell Physiol 283: C1705-C1714.
Fernández-Fernández JM, Andrade YN, Arniges M, Fernandes J, Plata C, Rubio-Moscardo F,
Vázquez E, and Valverde MA (2008) Functional coupling of TRPV4 cationic channel and large
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
conductance, calcium-dependent potassium channel in human bronchial epithelial cell lines.
Pflugers Arch 457: 149-159.
Ferraris JD and Burg MB (2006) Tonicity-dependent regulation of osmoprotective genes in
mammalian cells. Contrib Nephrol 152: 125-141.
Fu Y, Subramanya A, Rozansky D, and Cohen DM (2006) WNK kinases influence TRPV4 channel
function and localization. Am J Physiol Renal Physiol 290: F1305-F1314.
Galizia L, Flamenco MP, Rivarola V, Capurro C, and Ford P (2008) Role of AQP2 in activation of
calcium entry by hypotonicity: implications in cell volume regulation. Am J Physiol Renal Physiol
294: F582-F590.
Gerzanich V, Woo SK, Vennekens R, Tsymbalyuk O, Ivanova S, Ivanov A, Geng Z, Chen Z, Nilius B,
Flockerzi V, Freichel M, and Simard JM (2009) De novo expression of Trpm4 initiates secondary
hemorrhage in spinal cord injury. Nat Med 15: 185-191.
Guizouarn H and Motais R (1999) Swelling activation of transport pathways in erythrocytes: effects
of Cl-, ionic strength, and volume changes. Am J Physiol 276:C210-C220.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Grishin A, Ford H, Wang J, Li H, Salvador-Recatala V, Levitan ES, and Zaks-Makhina E (2005)
Attenuation of apoptosis in enterocytes by blockade of potassium channels. Am J Physiol
Gastrointest Liver Physiol 289: G815-G821.
Grunnet M, Jespersen T, MacAulay N, Jorgensen NK, Schmitt N, Pongs O, Olesen SP, and Klaerke
DA (2003) KCNQ1 channels sense small changes in cell volume. J Physiol 549: 419-427.
Guarnieri C, Muscari C, Finelli C, Caldarera CM (1993) Age-related changes in cardiac mitochondrial
energetics under the influence of calcium in rat. Cardioscience 4:117-120.
Hoffmann EK and Lambert IH (1983) Amino acid transport and cell volume regulation in Ehrlich
ascites tumour cells. J Physiol 338: 613-625.
Hoffmann EK. Cell swelling and volume regulation (1992) Can J Physiol Pharmacol. 70 S310-313.
Hoffmann EK, Lambert IH, and Pedersen SF (2009) Physiology of cell volume regulation in
vertebrates. Physiol Rev 89: 193-277.
Hosoi K (2016) Physiological role of aquaporin 5 in salivary glands. Pflugers Arch 468:519-539
Hughes FM., Bortner CD, Purdy GD, and Cidlowski JA (1997) Intracellular K+ suppresses the
activation of apoptosis in lymphocytes. J Biol Chem 272: 30567-30576.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Hyzinski-García MC, Rudkouskaya A, and Mongin AA (2014) LRRC8A protein is indispensable for
swelling-activated and ATP-induced release of excitatory amino acids in rat astrocytes. J Physiol
592: 4855-4862.
Inoue H, Ohtaki H, Nakamachi T, Shioda S, and Okada Y (2007) Anion channel blockers attenuate
delayed neuronal cell death induced by transient forebrain ischemia. J Neurosci Res 85:1427-1435.
Jentsch TJ, Lutter D, Planells-Cases R, Ullrich F, and Voss FK (2016) VRAC: molecular identification
as LRRC8 heteromers with differential functions. Pflugers Arch 468: 385-393.
Jin M1, Berrout J, Chen L, and O'Neil RG (2012) Hypotonicity-induced TRPV4 function in renal
collecting duct cells: modulation by progressive cross-talk with Ca2+-activated K+ channels. Cell
Calcium 51: 131-139.
Jo AO, Ryskamp DA, Phuong TT, Verkman AS, Yarishkin O, MacAulay N, and Križaj D (2015) TRPV4
and AQP4 Channels Synergistically Regulate Cell Volume and Calcium Homeostasis in Retinal
Müller Glia. J Neurosci 35: 13525-13537.
Jurkowitz-Alexander MS, Altschuld RA, Hohl CM, Johnson JD, McDonald JS, Simmons TD, and
Horrocks LA (1992) Cell swelling, blebbing, and death are dependent on ATP depletion and
independent of calcium during chemical hypoxia in a glial cell line (ROC-1). J Neurochem 59: 344-
352.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Kahle KT, Khanna AR, Alper SL, Adragna NC, Lauf PK, Sun D, and Delpire E (2015) K-Cl
cotransporters, cell volume homeostasis, and neurological disease. Trends Mol Med 21: 513-523
Kerr JF, Wyllie AH, and Currie AR (1972) Apoptosis: A basic biological phenomenon with
wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257.
Kinne RK (1993) The role of organic osmolytes in osmoregulation: from bacteria to mammals. J
Exp Zool 265:346-355.
Kirkegaard SS, Lambert IH, Gammeltoft S, and Hoffmann EK (2010) Activation of the TASK-2
channel after cell swelling is dependent on tyrosine phosphorylation. Am J Physiol Cell Physiol 299:
C844-C853.
Kondratskyi A, Kondratska K, Skryma R, and Prevarskaya N (2014) Ion channels in the regulation of
apoptosis. Biochim Biophys Acta 1848: 2532-2546.
Lambert IH and Hoffmann EK (1994) Cell swelling activates separate taurine and chloride channels
in Ehrlich mouse ascites tumor cells. J Membr Biol 142: 289-298.
Lambert IH, Kristensen DM, Holm JB, and Mortensen OH (2015) Physiological role of taurine--from
organism to organelle. Acta Physiol (Oxf) 213: 191-212.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Lang F, Madlung J, Uhlemann AC, Risler T, and Gulbins E (1998) Cellular taurine release triggered
by stimulation of the Fas(CD95) receptor in Jurkat lymphocytes. J Biol Chem 436: 377-383.
Lang F (2007) Mechanisms and significance of cell volume regulation. J Am Coll Nutr 26:613S-623S.
Lang F, Föller M, Lang KS, Lang PA, Ritter M, Gulbins E, Vereninov A, and Huber SM (2005) Ion
channels in cell proliferation and apoptotic cell death. J Membr Biol 205:147-157.
Lewis R, Feetham CH, and Barrett-Jolley R (2011) Cell volume regulation in chondrocytes. Cell
Physiol Biochem 28: 1111-1122.
Liedtke W and Friedman JM (2003) Abnormal osmotic regulation in trpv4-/- mice. Proc Natl Acad
Sci U S A 100: 13698-13703.
Linnik MD, Zobrist RH, Hatfield MD (1993) Evidence supporting a role for programmed cell death
in focal cerebral ischemia in rats. Stroke 24:2002-2008.
Liu X, Bandyopadhyay BC, Nakamoto T, Singh B, Liedtke W, Melvin JE, and Ambudkar I (2006) A
role for AQP5 in activation of TRPV4 by hypotonicity: concerted involvement of AQP5 and TRPV4
in regulation of cell volume recovery. J Biol Chem 281: 15485-15495.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Lohr JW and Grantham JJ (1986) Isovolumetric regulation of isolated S2 proximal tubules in
anisotonic media. J Clin Invest 78:1165–1172.
Maeno E, Ishizaki Y, Kanaseki T, Hazama A, and Okada Y (2000) Normotonic cell shrinkage because
of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci U S A 97:
9487-9492.
Maeno E, Takahashi N, Okada Y (2006) Dysfunction of regulatory volume increase is a key
component of apoptosis. FEBS Lett 580: 6513-6517.
Martínez-Valverde T, Vidal-Jorge M, Martínez-Saez E, Castro L, Arikan F, Cordero E, Radoi A, Poca
MA, Simard JM, and Sahuquillo J (2015) Sulfonylurea Receptor 1 in Humans with Post-Traumatic
Brain Contusions. J Neurotrauma 32: 1478-1487.
Matthews BD, Thodeti CK, Tytell JD, Mammoto A, Overby DR, and Ingber DE (2010) Ultra-rapid
activation of TRPV4 ion channels by mechanical forces applied to cell surface beta1 integrins.
Integr Biol (Camb) 2: 435-442.
Model MA (2014) Possible causes of apoptotic volume decrease: an attempt at quantitative
review. Am J Physiol Cell Physiol 306: C417-C424.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Mongin AA (2016) Volume-regulated anion channel-a frenemy within the brain. Pflugers Arch
468:421-441.
Morán J, Hernández-Pech X, Merchant-Larios H, and Pasantes-Morales H (2000) Release of taurine
in apoptotic cerebellar granule neurons in culture. Pflugers Arch 439: 271-277.
Morán J, Miranda D, Peña-Segura C, and Pasantes-Morales H (1997) Volume regulation in NIH/3T3
cells not expressing P-glycoprotein. II. Chloride and amino acid fluxes. Am J Physiol 272:C1804-
C1809.
Mountian I and Van Driessche W (1997) Isovolumetric regulation of C6 rat glioma cells in
hyperosmotic media. Am J Physiol 272:C318-C323.
Nagelhus EA, Horio Y, Inanobe A, Fujita A, Haug FM, Nielsen S, Kurachi Y, and Ottersen OP (1999)
Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal
Muller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains. Glia
26: 47-54.
Niemeyer MI, Cid LP, Barros LF, and Sepúlveda FV (2001) Modulation of the two-pore domain acid-
sensitive K+ channel TASK-2 (KCNK5) by changes in cell volume. J Biol Chem 276: 43166-43174.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Nilius B, Oike M, Zahradnik I, and Droogmans G (1994) Activation of a Cl- current by hypotonic
volume increase in human endothelial cells. J Gen Physiol 103: 787-805.
Nilius B, Eggermont J, Voets T, Buyse G, Manolopoulos V, and Droogmans G (1997) Properties of
volume-regulated anion channels in mammalian cells. Prog Biophys Mol Biol 68: 69-119.
Nilius B, Prenen J, Voets T, Eggermont J, and Droogmans G (1998) Activation of volume-regulated
chloride currents by reduction of intracellular ionic strength in bovine endothelial cells. J Physiol
506:353-361.
Nilius B, Voets T, Prenen J, Barth H, Aktories K, Kaibuchi K, Droogmans G, and Eggermont J (1999)
Role of Rho and Rho kinase in the activation of volume-regulated anion channels in bovine
endothelial cells. J Physiol 516: 67-74.
Nilius B, Droogmans G (2001) Ion channels and their functional role in vascular endothelium.
Physiol Rev. 81:1415-1459.
Nilius B, Prenen J, Voets T, Droogmans G (2004) Intracellular nucleotides and polyamines inhibit
the Ca2+-activated cation channel TRPM4b. Pflugers Arch.448:70-75.
Nilius B and Owsianik G (2011) The transient receptor potential family of ion channels. Genome
Biol 12:218.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Nilius B and Szallasi A (2014) Transient receptor potential channels as drug targets: from the
science of basic research to the art of medicine. Pharmacol Rev 66:676-814.
Numata T, Sato K, Christmann J, Marx R, Mori Y, Okada Y, Wehner F (2012) The ΔC splice-variant of
TRPM2 is the hypertonicity-induced cation channel in HeLa cells, and the ecto-enzyme CD38
mediates its activation. J Physiol. 590:1121-1138
Okada Y, Maeno E (2001) Apoptosis, cell volume regulation and volume-regulatory chloride
channels. Comp Biochem Physiol A Mol Integr Physiol. 130:377-383.
Okada Y (2004) Ion channels and transporters involved in cell volume regulation and sensor
mechanisms. Cell Biochem Biophys 41:233-258.
Okada Y, Shimizu T, Maeno E, Tanabe S, Wang X, and Takahashi N (2006) Volume-sensitive
chloride channels involved in apoptotic volume decrease and cell death. J Membr Biol 209: 21-29.
Olson JE, Sankar R, Holtzman D, James A, Fleischhacker D (1986) Energy-dependent volume
regulation in primary cultured cerebral astrocytes. J Cell Physiol 128:209-15.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Ordaz B, Vaca L, Franco R, and Pasantes-Morales H (2004) Volume changes and whole cell
membrane currents activated during gradual osmolarity decrease in C6 glioma cells: contribution
of two types of K+ channels. Am J Physiol Cell Physiol 286:C1399-C1409.
Orlov SN, Platonova AA, Hamet P, and Grygorczyk R (2013) Cell volume and monovalent ion
transporters: their role in cell death machinery triggering and progression. Am J Physiol Cell Physiol
305: C361-C372.
Owsianik G, D'Hoedt D, Voets T, and Nilius B (2006) Structure–function relationship of the TRP
channel superfamily. Rev Physiol Biochem Pharmacol 156: 61-90.
Pan Z, Yang H, Mergler S, Liu H, Tachado SD, Zhang F, Kao WW, Koziel H, Pleyer U, and Reinach PS
(2008) Dependence of regulatory volume decrease on transient receptor potential vanilloid 4
(TRPV4) expression in human corneal epithelial cells. Cell Calcium 44: 374-385.
Pasantes-Morales H, Lezama RA, Ramos-Mandujano G, and Tuz KL (2006) Mechanisms of cell
volume regulation in hypo-osmolality. Am J Med 119:S4-S11.
Pasantes-Morales H, Murray RA, Lilja L, and Morán J (1994) Regulatory volume decrease in
cultured astrocytes. I. Potassium- and chloride-activated permeability. Am J Physiol 266: C165-
C171.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Pasantes-Morales H, Quesada O, and Moran J (1998) Taurine: an osmolyte in mammalian tissues.
Adv Exp Med Biol 442: 209-217.
Pasantes-Morales H, Franco R, Torres-Marquez ME, Hernández-Fonseca K, and Ortega A (2000)
Amino Acid Osmolytes in Regulatory Volume Decrease and Isovolumetric Regulation in Brain Cells:
Contribution and Mechanisms. Cell Physiol Biochem 10:361–370.
Patel AJ and Lazdunski M (2004) The 2P-domain K+ channels: role in apoptosis and tumorigenesis.
Pflugers Arch 448: 261-273.
Pedersen SF, Hoffmann EK, Mills JW (2001) The cytoskeleton and cell volume regulation.
Comp Biochem Physiol A Mol Integr Physiol.130:385-399.
Pedersen SF, Owsianik G, and Nilius B (2005) TRP channels: an overview. Cell Calcium 38: 233-252.
Pedersen SF and Nilius B (2007) Transient Receptor Potential Channels in Mechanosensing and Cell
Volume Regulation, in Methods in Enzymology Volume 428 Osmosensing and Osmosignalign
(Dieter Häussinger and Helmut Sies eds) pp 183-207, Academic Press Elsevier, San Diego California
USA.
Pedersen SF, Klausen TK, and Nilius B (2015) The identification of a volume-regulated anion
channel: an amazing Odyssey. Acta Physiol (Oxf) 213: 868-881.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Pedersen SF, Okada Y, and Nilius B (2016) Biophysics and Physiology of the Volume-Regulated
Anion Channel (VRAC)/Volume-Sensitive Outwardly Rectifying Anion Channel (VSOR). Pflugers
Arch 468:371-383.
Pérez-Domínguez M, Hernández-Benítez R, Peña Segura C, Pasantes-Morales H (2014) Thrombin-
facilitated efflux of D-[3H]-aspartate from cultured astrocytes and neurons under hyponatremia
and chemical ischemia. Neurochem Res.39:1219-1231.
Phillis JW, Perkins LM, Smith-Barbour M, O'Regan MH (1995) Oxypurinol-Enhanced Postischemic
Recovery of the Rat Brain Involves Preservation of Adenine Nucleotides. J Neurochem. 64:2177-
2184.
Planells-Cases R, Lutter D, Guyader C, Gerhards NM, Ullrich F, Elger DA, Kucukosmanoglu A, Xu G,
Voss FK, Reincke SM, Stauber T, Blomen VA, Vis DJ, Wessels LF, Brummelkamp TR, Borst P,
Rottenberg S, Jentsch TJ (2015) EMBO J. 34:2993-3008.
Plant TD (2014) TRPs in mechanosensing and volume regulation. Handb Exp Pharmacol 223: 743-
766.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Platonova A, Ponomarchuk O, Boudreault F, Kapilevich LV, Maksimov GV, Grygorczyk R, Orlov SN
(2015) Role of cytoskeleton network in anisosmotic volume changes of intact and permeabilized
A549 cells. Biochim Biophys Acta. 1848, Part A :2337-2343.
Qiu Z, Dubin AE, Mathur J, Tu B, Reddy K, Miraglia LJ, Reinhardt J, Orth AP, and Patapoutian A
(2014) SWELL1, a plasma membrane protein, is an essential component of volume-regulated anion
channel. Cell 157: 447-458.
Remillard CV and Yuan JX (2004) Activation of K+ channels: an essential pathway in programmed
cell death. Am J Physiol Lung Cell Mol Physiol 286:L49-L67.
Ruiz-Martinez A, Vazquez-Juárez E, Ramos-Mandujano G, Pasantes-Morales H (2011) Permissive
effect of EGFR-activated pathways on RVI and their anti-apoptotic effect in hypertonicity-exposed
mIMCD3 cells. Biosci Rep. 31:489-497.
Sabirov RZ, Prenen J, Tomita T, Droogmans G, and Nilius B (2000) Reduction of ionic strength
activates single volume-regulated anion channels (VRAC) in endothelial cells. Pflugers Arch
439:315-320.
Sánchez-Olea R, Morán J, Schousboe A, and Pasantes-Morales H (1991) Hyposmolarity-activated
fluxes of taurine in astrocytes are mediated by diffusion. Neurosci Lett 130: 233-236.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Sánchez-Olea R, Morán J and Pasantes-Morales H (1992) Changes in taurine transport evoked by
hyperosmolarity in cultured astrocytes. J Neurosci Res 32: 86-92.
Shennan DB (2008) Swelling-induced taurine transport: relationship with chloride channels, anion-
exchangers and other swelling-activated transport pathways. Cell Physiol Biochem 21: 15-28.
Shimizu T, Lee EL, Ise T, and Okada Y (2008) Volume-sensitive Cl(-) channel as a regulator of
acquired cisplatin resistance. Anticancer Res 28:75-83.
Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L, Tsymbalyuk N, West GA, and
Gerzanich V (2006) Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral
edema after ischemic stroke. Nat Med 12: 433-440.
Simard JM, Woo SK, and Gerzanich V (2012) Transient receptor potential melastatin 4 and cell
death. Pflugers Arch 464: 573-582.
Simard JM, Woo SK, Schwartzbauer GT, and Gerzanich VJ (2014) Sulfonylurea receptor 1 in central
nervous system injury: a focused review. Cereb Blood Flow Metab. 32: 1699-1717.
Simon F, Leiva-Salcedo E, Armisén R, Riveros A, Cerda O, Varela D, Eguiguren AL, Olivero P, and
Stutzin A (2010) Hydrogen peroxide removes TRPM4 current desensitization conferring increased
vulnerability to necrotic cell death. J Biol Chem 285:37150-37158.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Sirianant L, Wanitchakool P, Ousingsawat J, Benedetto R, Zormpa A, Cabrita I, Schreiber R,
Kunzelmann K (2016) Non-essential contribution of LRRC8A to volume regulation. Pflugers Arch
468 :805-816.
Soe R, Macaulay N, and Klaerke DA (2009) Modulation of Kir4.1 and Kir4.1-Kir5.1 channels by small
changes in cell volume. Neurosci Lett 457: 80-84.
Song M and Yu SP (2014) Ionic regulation of cell volume changes and cell death after ischemic
stroke. Transl Stroke Res 5:17-27.
Souza MM, Boyle RT, and Lieberman M (2000) Different physiological mechanisms control
isovolumetric regulation and regulatory volume decrease in chick embryo cardiomyocytes. Cell
Biol Int 24:713-721.
Stauber T (2015) The volume-regulated anion channel is formed by LRRC8 heteromers – molecular
identification and roles in membrane transport and physiology. Biol Chem 396:975-990.
Stutzin A and Hoffmann EK (2006) Swelling-activated ion channels: functional regulation in cell-
swelling, proliferation and apoptosis. Acta Physiol 187:27-42.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Stutzin A, Torres R, Oporto M, Pacheco P, Eguiguren AL, Cid LP, and Sepúlveda FV (1999) Separate
taurine and chloride efflux pathways activated during regulatory volume decrease. Am J Physiol
277:C392-C402.
Strbák V (2011) Cell swelling-induced peptide hormone secretion. Cell Physiol Biochem 28:1155-
1168
Syeda R, Qiu Z, Dubin AE, Murthy SE, Florendo MN, Mason DE, Mathur J, Cahalan SM, Peters EC,
Montal M, and Patapoutian A (2016) LRRC8 Proteins Form Volume-Regulated Anion Channels that
Sense Ionic Strength. Cell 164:499-511.
Tejada MA, Stople K, Hammami Bomholtz S, Meinild AK, Poulsen AN, and Klaerke DA (2014) Cell
volume changes regulate slick (Slo2.1), but not slack (Slo2.2) K+ channels. PLoS One 9: e110833
Tuz K, Ordaz B, Vaca L, Quesada O, and Pasantes-Morales H (2001) Isovolumetric regulation
mechanisms in cultured cerebellar granule neurons. J Neurochem 79:143–151.
Varela D, Simon F, Riveros A, Jørgensen F, and Stutzin A (2004) NAD(P)H oxidase-derived H(2)O(2)
signals chloride channel activation in cell volume regulation and cell proliferation. J Biol Chem
279:13301-13304.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Verbalis JG and Gullans SR (1991) Hyponatremia causes large sustained reductions in brain content
of multiple organic osmolytes in rats. Brain Res 567: 274-282.
Voets T, Droogmans G, Raskin G, Eggermont J, and Nilius B (1999) Reduced intracellular ionic
strength as the initial trigger for activation of endothelial volume-regulated anion channels. Proc
Natl Acad Sci U S A 96: 5298-5303.
Voets T, Nilius B, Vennekens R (2015) VRACs swallow platinum drugs. EMBO J. 34:2985-2987
Voss FK, Ullrich F, Münch J, Lazarow K, Lutter D, Mah N, Andrade-Navarro MA, von Kries JP,
Stauber T, and Jentsch TJ (2014) Identification of LRRC8 heteromers as an essential component of
the volume-regulated anion channel VRAC. Science 344: 634-638.
Vriens J, Watanabe H, Janssens A, Droogmans G, Voets T, and Nilius B (2004) Cell swelling, heat,
and chemical agonists use distinct pathways for the activation of the cation channel TRPV4. Proc
Natl Acad Sci USA 101: 396-401.
Wehner F, Olsen H, Tinel H, Kin-Saffran E, and Kinne RK (2003) Cell volume regulation: osmolytes,
osmolyte transport, and signal transduction. Rev Physiol Biochem Pharmacol 148: 1-80.
Wehner F, Bondarava M, Ter Veld F, Endl E, Nürnberger HR, and Li T (2006) Hypertonicity-
induced cation channels. Acta Physiologica 187: 21-25.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Yu SP, Yeh CH, Sensi SL, Gwag BJ, Canzoniero LM, Farhangrazi ZS, Ying HS, Tian M, Dugan LL, Choi
DW (1997) Mediation of neuronal apoptosis by enhancement of outward potassium current.
Science 278: 114-117.
Yu SP and Choi DW (2000) Ions, cell volume, and apoptosis. Proc. Natl. Acad. Sci. USA 97: 9360-
9362.
Yu SP (2003) Regulation and critical role of potassium homeostasis in apoptosis. Prog Neurobiol
70: 363-386.
Zanou N, Mondin L, Fuster C, Seghers F, Dufour I, de Clippele M, Schakman O, Tajeddine N, Iwata
Y, Wakabayashi S, Voets T, Allard B, and Gailly P (2015) Osmosensation in TRPV2 dominant
negative expressing skeletal muscle fibres. J Physiol 593: 3849-3863.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
Figure Legends
Figure 1. Schematic illustration of the mechanisms mediating osmolyte fluxes during RVD. A.
Under isotonic conditions, water fluxes are in equilibrium and the cell volume corresponds
basically to that defined by the cell lineage. Upon a reduction in extracellular osmolarity, water
moves following its concentration gradient and the cell swells. Immediately after, intracellular
signals activate the channels and transporters mobilizing the main intracellular osmotically active
solutes: the ions K+, Cl
- and a number of organic molecules, mainly amines, amino acids and
polyalcohols. The massive efflux of osmolytes, drives osmotically obligated water and the volume
of the cell progressively decreases towards the original volume. K+ fluxes permeate through a
variety of channels, activated by events concurrent with cell swelling and are different in the
different cell types. Cl- fluxes are likely carried by one type of channel, identified as VRAC. Organic
osmolytes permeate through diffusive pathways, possibly molecular variants of the VRAC. KCC also
participates in the ion extrusion. B. Time course of the changes in cell volume (gray solid line) and
the efflux of 125
I- as tracer for Cl
- (B),
86Rb (tracer for K
+)(Δ) and
3H-taurine (B). Data from cultured
astrocytes C. Swelling and cell volume recovery in mesenchimal cells exposed to a reduction in
external osmolarity (unpublished).
Figure 2. Differences between the volume-sensitive efflux of Cl- and taurine. A.B. In HeLa cells (A)
and NIH3T3 cells (B), Cl- efflux traced by I
- (B) is fast and inactivates rapidly, while taurine efflux (B)
is sustained (see also Fig. 1B). C. Effects on ICl-swell and on
3H-taurine efflux of LCRR8 heteromer
knockout in HEK cells. D. Suggested LCRR8 multimeric composition of the two pathways, based on
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
the effect of LCRR8 heteromer knockout on ICl-swell and taurine efflux. ICl
-swell is abolished in
LCRR8A-/-
(black), markedly reduced in LCRR8B-/-
and LCRR8C-/-
(gray) and mildly decreased in
LCRR8D-/-
and LCRR8E-/-
(white). The taurine efflux pathway requires LCRR8A and LCRR8D but
none of the other subunits of the complex. Details in Stutzin et al., 1999; Morán et al., 1997, Voss
et al., 2014, Qiu et al., 2014; Planells-Cases et al., 2015.
Figure 3. Cl- currents (C6 glioma cells) and taurine efflux (cerebellar granule neurons) evoked by
small and gradual osmolarity reductions . A. In cerebellar granule neurons, sudden 30% reduction
or increase in external osmolarity induces cell swelling or shrinkage, respectively, followed by RVD
or RVI. When osmolarity reductions imposed to the cell are gradual and small, the cell volume
remains unchanged, by the set in motion of an active process of osmolyte extrusion, known as
isovolumetric regulation (IVR). Efflux of taurine, glutamate, K+ and Cl
-, all contribute to the cell
volume adjustment. Efflux thresholds in these cells were -2% and -19%, for [3H]taurine and D-
[3H]aspartate (as marker for glutamate), respectively, and -25% and -29%, respectively, for Cl- (
125I)
and K+ (86
Rb). B. ICl-swell activated by small and gradual changes in osmolarity in glioma C6 cells.
Upper panel: ICl-swell at the osmolarity indicated in the conductance plot (middle panel). Lower
panel left, I-V curves in cells in isotonic medium and at 33% osmolarity reduction. Lower panel
right: effect of the Cl− channel blockers niflumic acid (NA) and NPPB on the Cl
− current elicited by
gradual reductions in osmolarity. Details in Ordaz et al., 2004; Tuz et al. 2001.
Figure 4. Channels and transporters involved in RVI. A. Schematic representation of channels and
transporters involved in the volume adjustment after hypertonicity-induced cell shrinkage. B. Cell
volume reduction and RVI in a renal cell line, mIMCD3, exposed to media made hypertonic by
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
MOL#104158
addition of NaCl. C. Increase in intracellular osmolyte amino acid levels in astrocytes cultured in
hypertonic medium. Details in Ruiz-Martinez et al., 2011, Sanchez-Olea et al., 1992.
Fig. 5. Role of ion channels and transporters on necrotic volume increase and excitotoxic
(necrotic) neuronal death at the penumbra area during brain ischemia. A. The chain of events
leading to NVI and cell death. The oxygen reduction leads to: energy failure, ATPase dysfunction,
dissipation of K+ and Na
+ transmembrane gradients, rise in K
+o levels and KCC reversal. Ischemia-
induced expression of TRPM4 and NKCC leads to massive Na+ overload. All this results in astrocyte
swelling and VRAC-mediated glutamate efflux. Reversal of the Na+- dependent glutamate
transporter increases further the extracellular glutamate levels. Overfunction of the neuronal
NMDA and AMPA neuronal receptors generates Na+ and Ca
2+ overload, together with Cl
- influx
through VRAC driven induced by the ischemic depolarizing condition. All this culminates in NVI
and the necrotic cascade. Noticeable, excitotoxicity also activates the apoptotic machinery. B.
Time course of astrocyte swelling (gray solid line) and glutamate (B) (traced by 3H-D- aspartate)
efflux from cultured cortical astrocytes. Glutamate efflux is abolished by simultaneous treatment
with the VRAC blockers DIDS and phloretin and transporter blockers (TBOA). Details in Perez-
Dominguez et al., 2014.
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from
This article has not been copyedited and formatted. The final version may differ from this version.Molecular Pharmacology Fast Forward. Published on June 29, 2016 as DOI: 10.1124/mol.116.104158
at ASPE
T Journals on A
ugust 27, 2020m
olpharm.aspetjournals.org
Dow
nloaded from